This inventor holds 1 USPTO granted patent. Top assignee: The University of Melbourne. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Michael Francis Duffy: Innovator in Mycoplasma Vaccines
Introduction
Michael Francis Duffy is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of immunology, particularly in the development of vaccines against Mycoplasma infections. His work is characterized by a focus on creating effective immunogens that can be utilized in vaccine preparations.
Latest Patents
Duffy holds a patent for "Mycoplasma recombinant polypeptides and vaccines." This invention relates to immunogens and their application in vaccine formulations. Specifically, it involves peptides or polypeptides that correspond to, mimic, or cross-react with B-cell or T-cell epitopes on surface polypeptides. The immunogens developed through this patent are particularly beneficial for the prophylactic and therapeutic treatment of individuals against infections caused by Mycoplasma species. Additionally, the invention provides diagnostic reagents for detecting Mycoplasma in biological samples from suspected infected individuals. He has 1 patent to his name.
Career Highlights
Duffy is affiliated with the University of Melbourne, where he continues to advance research in immunology and vaccine development. His academic and research endeavors have positioned him as a key figure in the field.
Collaborations
Throughout his career, Duffy has collaborated with esteemed colleagues, including Kevin George Whithear and Glenn Francis Browning. These partnerships have enhanced the scope and impact of his research.
Conclusion
Michael Francis Duffy's innovative work in the development of Mycoplasma vaccines showcases his commitment to advancing medical science. His contributions are vital for improving public health through effective immunization strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
